Best of BusinessDesk: Migrant exploitation reporting rates soar

Best of BusinessDesk: Migrant exploitation reporting rates soar
Migrants with a temporary protection visa are at risk of being "re-exploited" due to lack of wraparound support, according to an advocate. (Image: Getty)
Murray Jones
This story by Murray Jones, published in July, was a popular read on BusinessDesk in 2024.The number of reports of migrant exploitation to Immigration NZ has increased significantly in the past year. Data obtained under the Official Information Act (OIA) by BusinessDesk shows that the number of complaints relating to migrant exploitation has risen 199% in a year, from 899 between July 1, 2022, and June 30, 2023, to 2,684 in the 10 months up to April 30. The Ministry of Business, Innovation and Employment (MBIE) attributed the rise to...

More Law & Regulation

Du Val receivers PwC still trying to sell three properties
Property

Du Val receivers PwC still trying to sell three properties

Du Val properties in Waitākere, Henderson, and Māngere are still being marketed by receivers PwC despite an expressions-of-interest campaign that opened in October and closed toward the end of November.On Oct 25, nearly 1ha of land planned to serve as the site for many new homes...

Staff reporters 14 Feb 2025
EPA 'technically insolvent' over $10m govt loan
Law & Regulation

EPA 'technically insolvent' over $10m govt loan

The EPA will repay the loan from fast-track consenting levies charged to applicants.

Greg Hurrell 14 Feb 2025
Former Grant Thornton partner guilty of misconduct
Finance

Former Grant Thornton partner guilty of misconduct

Tribunal decision shows Peter Sherwin failed to disclose potential conflicts. 

Victoria Young 14 Feb 2025
Class action targets ‘ineffective’ cold medicines
Law & Regulation

Class action targets ‘ineffective’ cold medicines

A class action has been filed claiming a pharmaceutical giant sold and marketed in New Zealand cold medicines that did not work.Australia-based JGA Saddler filed a class action against Johnson & Johnson NZ on Thursday over its phenylephrine-based cold medicines tablets and syrups...

Staff reporters 13 Feb 2025